|
|
||||||||
Original Research |
Expression by Preventing NF-
B Activation
Graduate Center for Nutritional Sciences (Y.Z., L.H.C.), Internal Medicine (S.J.-B., S.B.), University of Kentucky, Lexington, KY
Address reprint requests to: Dr. Linda Chen, Graduate Center for Nutritional Sciences, 204 Funkhouser Building, University of Kentucky, Lexington, KY 40506-0054. Phone: (859) 257-3288. E-mail: lchen{at}uky.edu
Background: Many studies have shown that fish oil supplementation inhibits tumor necrosis factor-
(TNF-
) production in mice and human subjects; however, the mechanisms remain unclear. Nuclear factor-
B (NF-
B) is a transcription factor that plays an important role in controlling the expression of pro-inflammatory genes including TNF-
. Activation of NF-
B has been shown to mediate the maximal expression of TNF-
in human monocytes. NF-
B is kept in an inactive form in the cytoplasm by I
B, the inhibitory subunit of NF-
B complex. Phosphorylation and subsequent degradation of I
B lead to NF-
B activation.
Objectives: The effect of eicosapentaenoic acid (EPA), a major n-3 fatty acid in fish oil, on the lipopolysaccharide (LPS)-induced expression of TNF-
and activation of NF-
B were investigated. The mechanism underlying EPA modulation of NF-
B activation was also studied.
Methods: Human monocytic THP-1 cells were pre-incubated with EPA and stimulated with LPS. The levels of secreted TNF-
were determined by ELISA. The DNA binding activity of NF-
B was analyzed by EMSA. The degradation and phosphorylation of I
B-
were examined by Western blot analysis.
Results: TNF-
production and expression induced by LPS were significantly decreased in cells pre-incubated with EPA. LPS-induced NF-
B activation, translocation of p65 subunit to the nucleus, phosphorylation and degradation of I
B-
were partially prevented by EPA.
Conclusions: The results suggest that suppression of the TNF-
expression by EPA is partly attributed to its inhibitory effect on NF-
B activation. EPA appears to prevent NF-
B activation by preventing the phosphorylation of I
B-
.
Key words: eicosapentaenoic acid, fish oil, LPS, TNF-
, NF-
B, I
B-
This article has been cited by other articles:
![]() |
E. Higashihara, K. Nutahara, S. Horie, S. Muto, T. Hosoya, K. Hanaoka, K. Tuchiya, K. Kamura, K. Takaichi, Y. Ubara, et al. The effect of eicosapentaenoic acid on renal function and volume in patients with ADPKD Nephrol. Dial. Transplant., September 1, 2008; 23(9): 2847 - 2852. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Tanaka, Y. Ishikawa, M. Yokoyama, H. Origasa, M. Matsuzaki, Y. Saito, Y. Matsuzawa, J. Sasaki, S. Oikawa, H. Hishida, et al. Reduction in the Recurrence of Stroke by Eicosapentaenoic Acid for Hypercholesterolemic Patients: Subanalysis of the JELIS Trial Stroke, July 1, 2008; 39(7): 2052 - 2058. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. Diaz Encarnacion, G. M. Warner, C. E. Gray, J. Cheng, H. K. H. Keryakos, K. A. Nath, and J. P. Grande Signaling pathways modulated by fish oil in salt-sensitive hypertension Am J Physiol Renal Physiol, June 1, 2008; 294(6): F1323 - F1335. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. K. Kiecolt-Glaser, M. A. Belury, K. Porter, D. Q. Beversdorf, S. Lemeshow, and R. Glaser Depressive Symptoms, omega-6:omega-3 Fatty Acids, and Inflammation in Older Adults Psychosom Med, April 1, 2007; 69(3): 217 - 224. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Rolph, T. R. Young, B. O. V. Shum, C. Z. Gorgun, C. Schmitz-Peiffer, I. A. Ramshaw, G. S. Hotamisligil, and C. R. Mackay Regulation of Dendritic Cell Function and T Cell Priming by the Fatty Acid-Binding Protein aP2 J. Immunol., December 1, 2006; 177(11): 7794 - 7801. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. J. Auborn Can Indole-3-Carbinol-Induced Changes in Cervical Intraepithelial Neoplasia Be Extrapolated to Other Food Components? J. Nutr., October 1, 2006; 136(10): 2676S - 2678S. [Full Text] [PDF] |
||||
![]() |
A. A. Farooqui, W.-Y. Ong, and L. A. Horrocks Inhibitors of Brain Phospholipase A2 Activity: Their Neuropharmacological Effects and Therapeutic Importance for the Treatment of Neurologic Disorders Pharmacol. Rev., September 1, 2006; 58(3): 591 - 620. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. C Calder n-3 Polyunsaturated fatty acids, inflammation, and inflammatory diseases Am. J. Clinical Nutrition, June 1, 2006; 83(6): S1505 - 1519S. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Jia, H.-R. Zhou, Y. Shi, and J. J. Pestka Docosahexaenoic Acid Consumption Inhibits Deoxynivalenol-Induced CREB/ATF1 Activation and IL-6 Gene Transcription in Mouse Macrophages J. Nutr., February 1, 2006; 136(2): 366 - 372. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. E. Loscher, E. Draper, O. Leavy, D. Kelleher, K. H. G. Mills, and H. M. Roche Conjugated Linoleic Acid Suppresses NF-{kappa}B Activation and IL-12 Production in Dendritic Cells through ERK-Mediated IL-10 Induction J. Immunol., October 15, 2005; 175(8): 4990 - 4998. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |